Changeflow GovPing Healthcare Assay and Point of Care Device Utilizing Saliva...
Routine Notice Added Final

Assay and Point of Care Device Utilizing Saliva for Neurological Diagnosis

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Health Informatics (G16H)
Published March 25th, 2026
Detected April 1st, 2026
Email

Summary

The European Patent Office published patent application EP3721228A1 for Flotbi Inc., covering an assay and point-of-care device that uses saliva for diagnosis and treatment of neurological conditions affecting brain health. Inventors include Janigro, Dudas, and Rapp. The patent, originally filed November 11, 2021, covers IPC classifications related to immunological assays, medical diagnostics computing, and protein analysis.

What changed

EPO published patent EP3721228A1 granting Flotbi Inc. intellectual property protection for a saliva-based assay and point-of-care diagnostic device designed for neurological condition diagnosis and brain health assessment. The patent names inventors JANIGRO, Damir, DUDAS, Aaron, and RAPP, Edward J., with designated states covering all EPC contracting states (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

Medical device manufacturers and pharmaceutical companies developing neurological diagnostic tools should review this granted patent to assess freedom-to-operate implications for related product development. No immediate compliance action is required, but entities in the neurological diagnostics space should evaluate potential licensing needs or design-around considerations.

Source document (simplified)

← EPO Patent Bulletin

ASSAY AND POINT OF CARE DEVICE UTILIZING SALIVA FOR DIAGNOSIS AND TREATMENT OF NEUROLOGICAL CONDITIONS AFFECTED BRAIN HEALTH

Publication EP3721228A1 Kind: A1 Mar 25, 2026

Applicants

Flotbi Inc.

Inventors

JANIGRO, Damir, DUDAS, Aaron, RAPP, Edward J.

IPC Classifications

G01N 33/53 20060101AFI20211111BHEP G16H 50/20 20180101ALI20211111BHEP G01N 33/543 20060101ALI20211111BHEP G01N 33/68 20060101ALI20211111BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Assay and Point of Care Device Utilizing Saliva for Diagnosis and Treatment of Neurological Conditions Affected Brain Health

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3721228A1

Who this affects

Applies to
Healthcare providers Medical device makers Pharmaceutical companies
Industry sector
3345 Medical Device Manufacturing 6211 Healthcare Providers 3254 Pharmaceutical Manufacturing
Activity scope
Medical Device Patents Neurological Diagnostics Point-of-Care Testing
Geographic scope
European Union EU

Taxonomy

Primary area
Healthcare
Operational domain
Intellectual Property
Topics
Healthcare Pharmaceuticals Medical Devices

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Health Informatics (G16H) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.